Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned
Annals of Surgical Oncology, 06/30/09
Choti MA - Curative resection of liver metastases from colorectal cancer is associated with improved overall survival rates, making complete resection the goal of therapy for many patients. The addition of newer, more active chemotherapeutic regimens has prolonged patient survival in those with advanced disease and increased the number of patients eligible for surgical therapy.
Related Articles
Herbal and Dietary Supplement Hepatotoxicity
Seminars in Liver Disease, 10/16/09
Relevance Score: 83%
Treatment of multiple sclerosis: role of natalizumab
Neurological Sciences, 11/18/09
Relevance Score: 80%
The management of paracetamol poisoning
Paediatrics and Child Health, 11/09/09
Relevance Score: 80%
Inhibitory effect of evodiamine alone and in combination with rosiglitazone on in vitro adipocyte differentiation and in vivo obesity related to diabetes
International Journal of Obesity, 11/02/09
Relevance Score: 80%
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/29/09
Relevance Score: 77%
Today in Hepatobiliary/Pancreas...keeping you current
Receive free subspecialty "5-minute updates" via email
Single HCC smaller than 2 cm: surgery or ablation
Journal of Hepato-Biliary-Pancreatic Surgery, 11/25/09
One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008
Journal of Hepato-Biliary-Pancreatic Surgery, 11/25/09
Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma
Journal of Surgical Oncology, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


